Protein linked to growth of organs and cancerAugust 12, 2005Johns Hopkins scientists have identified a protein in fruit flies whose counterpart product in humans may help cause cancer. The researchers report in the Aug. 12 issue of Cell that a protein dubbed Yorkie directly controls the fruit fly's organ size and, when overabundant, causes increased cell growth and decreased cell death, hallmarks of cancer. Yorkie's relative in mammals, called YAP, appears to do the same thing, the researchers report, which suggests that in humans, a defect in the gene that makes YAP might contribute to cancer. "Over the past few decades, science has identified a few so-called oncogenes, whose protein products act as accelerators and trigger abnormal cell growth," said Duojia Pan, Ph.D., who carried out most of the study at the University of Texas Southwestern Medical Center at Dallas before coming to the Johns Hopkins Institute for Basic Biomedical Sciences. "YAP seems to be another one and our lab is already investigating the amount of YAP protein in human tumors to see if excessive amounts are there." The researchers also report Yorkie directly regulates the size of all the fruit fly's organs. "We were surprised to find that by adding Yorkie to levels above normal, the fruit fly's organs grew larger," said Pan. "Likewise, by removing Yorkie to levels below normal, the fruit fly's organs were smaller than usual." The new findings build on Pan's earlier studies, which showed that fruit flies missing a gene called hippo developed tumors. That study revealed a tumor-suppression pathway involving proteins made by hippo and two other like-minded genes, all three of which function in a chain reaction to chemically add phosphate to other proteins, a process called phosphorylation. "From those results, we predicted that another protein must be involved in the tumor-suppression pathway that is a target of the phosphorylation cascade," said Pan. Yorkie turns out to be that "mystery protein," the researchers report. In their experiments, Pan and his colleagues show that the hippo phosphorylation cascade, by adding a phosphate group to the Yorkie protein, turns it off. When the scientists engineered reduced levels of hippo and other proteins that keep Yorkie in check, Yorkie caused tissues to overgrow by prompting more cells to grow and fewer to die, the hallmarks of cancer. Further experiments in the fruit fly that replaced Yorkie with YAP showed both proteins play similar roles, suggesting YAP might participate in a tumor-related pathway in mammals. Pan is now trying to identify the signal that tells genes like hippo to turn on or off once an organ grows to the appropriate size. That signal could be harnessed for therapeutics against cancer. The authors of the paper besides Pan are Shian Wu from Hopkins, and Jianbin Huang, Jose Barrera and Krista Matthews from UT Southwestern. The study was funded by the National Institutes of Health. Johns Hopkins Medical Institutions |
|||||||||||||||||||||
| Related Cause Of Cancer Current Events and Cause Of Cancer News Articles UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results. Blood vessels might predict prostate cancer behavior A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? Discovery offers potential new pancreatic cancer treatment Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein. Researchers use drug-radiation combo to eradicate lung cancer Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation. Experts issue call to reconsider screening for breast cancer and prostate cancer Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association." Resident physicians seldom trained in skin cancer examination Many resident physicians are not trained in skin cancer examinations, nor have they ever observed or practiced the procedure. Detecting the undetectable in prostate cancer screening A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. Parasite growth hormone pushes human cells to liver cancer Scientists have found that the human liver fluke (Opisthorchis viverrini) contributes to the development of bile duct (liver) cancer by secreting granulin, a growth hormone that is known to cause uncontrolled growth of cells. More Cause Of Cancer Current Events and Cause Of Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||